data_1kb7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kb7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.2 p -93.18 148.48 21.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 124.057 0.848 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.7 t -66.06 -51.95 53.44 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 118.455 -0.784 . . . . 0.0 113.07 175.775 -176.783 167.231 -87.761 109.051 1.996 108.767 151.493 64.987 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.25 108.61 19.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.929 0.786 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 m -135.53 -67.97 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 34.6 m -88.15 134.29 33.81 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.59 90.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.859 0.838 . . . . 0.0 111.292 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -157.85 140.65 14.86 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.72 92.23 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -13.9 61.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -72.83 -53.65 10.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.054 1.297 . . . . 0.0 113.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.1 121.46 84.0 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.457 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -71.82 154.87 58.69 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 123.149 2.566 . . . . 0.0 114.185 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -73.45 114.29 11.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.067 0.547 . . . . 0.0 110.04 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.82 36.77 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -80.98 148.85 29.58 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.032 1.416 . . . . 0.0 113.608 -177.199 64.987 151.493 -87.761 108.767 1.996 109.051 167.231 -176.783 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -91.21 122.5 33.9 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.037 1.875 . . . . 0.0 108.719 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.2 p -93.18 148.48 21.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 124.057 0.848 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.7 t -66.06 -51.95 53.44 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 118.455 -0.784 . . . . 0.0 113.07 175.775 -176.783 167.231 -87.761 109.051 1.996 108.767 151.493 64.987 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.25 108.61 19.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.929 0.786 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 m -135.53 -67.97 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 34.6 m -88.15 134.29 33.81 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.59 90.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.859 0.838 . . . . 0.0 111.292 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -157.85 140.65 14.86 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.72 92.23 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -13.9 61.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -72.83 -53.65 10.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.054 1.297 . . . . 0.0 113.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.1 121.46 84.0 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.457 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -71.82 154.87 58.69 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 123.149 2.566 . . . . 0.0 114.185 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -73.45 114.29 11.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.067 0.547 . . . . 0.0 110.04 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.82 36.77 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -80.98 148.85 29.58 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.032 1.416 . . . . 0.0 113.608 -177.199 64.987 151.493 -87.761 108.767 1.996 109.051 167.231 -176.783 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -91.21 122.5 33.9 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.037 1.875 . . . . 0.0 108.719 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.2 p -93.18 148.48 21.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 124.057 0.848 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.7 t -66.06 -51.95 53.44 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 118.455 -0.784 . . . . 0.0 113.07 175.775 -176.783 167.231 -87.761 109.051 1.996 108.767 151.493 64.987 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.25 108.61 19.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.929 0.786 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 m -135.53 -67.97 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 34.6 m -88.15 134.29 33.81 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.59 90.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.859 0.838 . . . . 0.0 111.292 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -157.85 140.65 14.86 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.72 92.23 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -13.9 61.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -72.83 -53.65 10.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.054 1.297 . . . . 0.0 113.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.1 121.46 84.0 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.457 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -71.82 154.87 58.69 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 123.149 2.566 . . . . 0.0 114.185 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -73.45 114.29 11.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.067 0.547 . . . . 0.0 110.04 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.82 36.77 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -80.98 148.85 29.58 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.032 1.416 . . . . 0.0 113.608 -177.199 64.987 151.493 -87.761 108.767 1.996 109.051 167.231 -176.783 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -91.21 122.5 33.9 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.037 1.875 . . . . 0.0 108.719 -179.804 . . . . . . . . 0 0 . 1 stop_ save_